SNX18P14

Across TCGA patient cohorts, SNX18P14 RNA expression is significantly associated with the go_rna of many other GO terms, with 6,677 significant associations in total. PRAD shows the largest number of these associations.

The most reproducible SNX18P14-associated GO terms across cancer lineages are Peptidyl-lysine modification, RNA methylation, and Nuclear-transcribed mRNA catabolic process, nonsense-mediated decay. Each is linked with SNX18P14 in more than 15 cancer types. Because this analysis shows association rather than direction, both SNX18P14-to-partner and partner-to-SNX18P14 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Peptidyl-lysine modification grouped by SNX18P14-low versus SNX18P14-high in ESCA.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (SNX18P14→partner) and Y-score (partner→SNX18P14) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
ESCA	Peptidyl-lysine modification →	+0.048	+0.485	<.001	.001	3	16
STAD	RNA methylation →	+0.045	+0.192	<.001	<.001	3	15
STAD	Nuclear-transcribed mRNA catabolic process, nonsense-mediated decay →	+0.060	+0.196	<.001	<.001	3	15
STAD	Cytoplasmic translational initiation →	+0.057	+0.254	<.001	<.001	3	15
STAD	Receptor metabolic process →	+0.054	+0.190	<.001	.001	3	15
STAD	Protein acylation →	+0.044	+0.273	<.001	<.001	2	16

Each partner links to its Q-omics profile. Showing the 6 strongest of 6,677 associations by consensus.

Peptidyl-lysine modification by SNX18P14 expression — ESCA

Explore this box plot interactively →